Roman M Chabanon

6PUBLICATIONS
57CO-AUTHORS
Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Roman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki

|Oct 16, 2024
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors.

Asuka Kawai-Kawachi, Madison M Lenormand, Clémence Astier

|Mar 15, 2022
A Novel Synthetic Lethal Approach to Target MYC-Driven Cancers.

Roman M Chabanon, Sophie Postel-Vinay

|Aug 11, 2021
Targeting the DNA damage response in immuno-oncology: developments and opportunities.

Roman M Chabanon, Mathieu Rouanne, Christopher J Lord

|Apr 23, 2021
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.

Roman M Chabanon, Daphné Morel, Thomas Eychenne

|May 28, 2019
Beyond DNA repair: the novel immunological potential of PARP inhibitors.

Roman M Chabanon, Jean-Charles Soria, Christopher J Lord

Pageof 1